Spectral AI Investor Deck Reveals $150M BARDA Contract and Commercial Launch Timeline
MDAI sits 35% above its 52-week low of $1.18.
Summary
Spectral AI furnished an investor presentation detailing its $150M BARDA contract, $14.0M cash position, and commercial launch plans for its FDA-cleared DeepView wound imaging system.
Key Events · Product Development and Regulatory · MDAI
-
Investor Presentation Filed
Spectral AI posted an investor presentation dated September 14, 2026, to its website and furnished it as Exhibit 99.1 to this 8-K.
-
$150M BARDA Contract Disclosed
The presentation discloses a $150M Project BioShield contract with BARDA, of which $86.6M is committed to date, with $63.4M in options not yet exercised at the government's discretion.
-
Balance Sheet and H1 2026 Results
As of June 30, 2026, cash was $14.0M, total assets $19.4M, notes payable $14.9M, total liabilities $31.5M, and stockholders' deficit $(12.1)M. H1 2026 revenue was $7.5M with an operating loss of $(6.3)M.
-
Commercial Launch Timeline
First commercial sales are targeted by year-end 2026, with planned deployment of up to 30 DeepView systems subsidized by BARDA through June 2027.
Analysis · MDAI · Industrial Applications And Services
The investor presentation furnished as an 8-K exhibit offers the most detailed public view yet of Spectral AI's commercial launch strategy following FDA De Novo clearance in May 2026. It discloses a $150M BARDA contract with $86.6M committed to date, a balance sheet showing $14.0M in cash against $31.5M in total liabilities, and a targeted timeline for first commercial sales by year-end 2026. Against the backdrop of Q2 2026's accelerating cash burn and declining revenue, this presentation is a critical update on how the company plans to convert its regulatory milestone into recurring revenue.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.9% of the 1656 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MDAI was trading at $1.59 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $51.2M. The 52-week trading range was $1.18 to $2.97. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.